Cryoport, Inc.

NasdaqCM CYRX

Cryoport, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2024: USD -72.31 M

Cryoport, Inc. Operating Income is USD -72.31 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -28.39% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Cryoport, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -56.32 M, a -92.68% change year over year.
Cryoport, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -29.23 M, a -51.35% change year over year.
Cryoport, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -19.31 M, a 8.22% change year over year.
Cryoport, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -21.04 M, a -10.65% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

NasdaqCM: CYRX

Cryoport, Inc.

CEO	Mr. Jerrell W. Shelton
IPO Date	Aug. 22, 2005
Location	United States
Headquarters	112 Westwood Place
Employees	1,100
Sector	Industrials
Industries Warehousing Biotechnology Container Shipping Containers & Packaging Frozen Foods Meat Non-Alcoholic Beverages Vaccines

Description

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Key trends

Past 5 years